project id: TCGA-LUAD; case submitter id: TCGA-05-4389; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 70; days to birth: -25660; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1935; age at diagnosis: 25660; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1369.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.356164383561644; pack years smoked: 43.0; is ffpe: false; portion number: 01; weight: 142.0; composition: Not Reported; intermediate dimension: 0.9; longest dimension: 1.3; preservation method: Unknown; shortest dimension: 0.3; sample id: ed61ac6a-f21f-4b88-928a-029340d4aebd; sample submitter id: TCGA-05-4389-01A; portion id: 72cc001d-aa82-4d54-ab27-334657ec00eb; portion submitter id: TCGA-05-4389-01A-01; percent necrosis: 3.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 82.0; percent tumor nuclei: 75.0;